These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1999680)

  • 21. Enhanced potency of truncated insulin-like growth factor-I (des(1-3)IGF-I) relative to IGF-I in lit/lit mice.
    Gillespie C; Read LC; Bagley CJ; Ballard FJ
    J Endocrinol; 1990 Dec; 127(3):401-5. PubMed ID: 2280209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of IGF-I infusion on growth and muscle Na(+)-K+ pump concentration in K(+)-deficient rats.
    Dørup I; Flyvbjerg A
    Am J Physiol; 1993 May; 264(5 Pt 1):E810-5. PubMed ID: 8388640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury.
    Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Oka T; Takenaka A; Takahashi S; Noguchi T
    JPEN J Parenter Enteral Nutr; 1997; 21(2):55-62. PubMed ID: 9084006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats.
    Chen K; Okuma T; Okamura K; Tabira Y; Kaneko H; Miyauchi Y
    JPEN J Parenter Enteral Nutr; 1995; 19(2):119-24. PubMed ID: 7609275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral amino acid intake alters the anabolic actions of insulin-like growth factor I in rats.
    Kee AJ; Baxter RC; Carlsson AR; Smith RC
    Am J Physiol; 1999 Jul; 277(1):E63-72. PubMed ID: 10409129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats.
    Read LC; Tomas FM; Howarth GS; Martin AA; Edson KJ; Gillespie CM; Owens PC; Ballard FJ
    J Endocrinol; 1992 Jun; 133(3):421-31. PubMed ID: 1613443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I, a potent IGF analogue, on growth hormone and IGF-binding protein secretion from cultured rat anterior pituitary cells.
    Simes JM; Wallace JC; Walton PE
    J Endocrinol; 1991 Jul; 130(1):93-9. PubMed ID: 1715381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats.
    Frampton RJ; Jonas HA; MacMahon RA; Larkins RG
    J Dev Physiol; 1990 Mar; 13(3):125-33. PubMed ID: 2177488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I.
    Brink M; Price SR; Chrast J; Bailey JL; Anwar A; Mitch WE; Delafontaine P
    Endocrinology; 2001 Apr; 142(4):1489-96. PubMed ID: 11250929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
    JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins.
    Guan J; Williams CE; Skinner SJ; Mallard EC; Gluckman PD
    Endocrinology; 1996 Mar; 137(3):893-8. PubMed ID: 8603600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
    Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations.
    Thissen JP; Underwood LE; Maiter D; Maes M; Clemmons DR; Ketelslegers JM
    Endocrinology; 1991 Feb; 128(2):885-90. PubMed ID: 1989867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys.
    Tomas FM; Walton PE; Dunshea FR; Ballard FJ
    J Endocrinol; 1997 Nov; 155(2):377-86. PubMed ID: 9415072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of insulin-like growth factor-I, but not growth hormone, increases maternal weight gain in late pregnancy without affecting fetal or placental growth.
    Gargosky SE; Owens JA; Walton PE; Owens PC; Wallace JC; Ballard FJ
    J Endocrinol; 1991 Sep; 130(3):395-400. PubMed ID: 1719115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Des (1-3) IGF-I potently enhances differentiated cell growth in olfactory bulb organ culture.
    Russo VC; Werther GA
    Growth Factors; 1994; 11(4):301-11. PubMed ID: 7779409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.